Health care CEO salaries, UnitedHealth’s busy week
Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences…
Will the US dodge a recession? Economist weighs in on Trump policies
Trump’s budget bill will impact every aspect of the economy The budget bill just passed and signed into…
COVID-19 surges nationwide — and the highest rates are in California
COVID-19 rates in the Southwestern United States reached 12.5% — the highest in the nation — according to…
PBS is slashing its budget in response to Trump’s war on public media
In an email sent out to PBS station managers on Wednesday, PBS president and CEO Paula Kerger announced…
Inside the Biden Administration’s Gamble to Freeze China’s AI Future
Then there were the specifics. How would the policy distinguish between equipment that really posed a risk, and…
RFK Jr. Is Supporting mRNA Research—Just Not for Vaccines
One of the targeted recipients, Tiba Biotech, had a $750,000 contract with BARDA that was slated to end…
New York claims Zelle’s shoddy security enabled a billion dollars in scams
New York Attorney General Letitia James is suing the banks behind Zelle over claims that their payment platform…
Staff cuts are undermining federal research on how to make health care better
WASHINGTON — A small federal agency that studies how to improve the health care system has been rendered…
Krafton claims former Subnautica 2 devs ‘lost interest’ in developing game
Krafton has fired another shot in its legal battle with former executives of Subnautica 2 studio Unknown Worlds,…
Trump screwed over Nvidia’s Chinese sales, then let them happen
Hello there, world! Welcome to the first issue of Regulator, a newsletter about the collision between Big Tech…
Medicare Advantage research machine, A big home health deal
Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences…
Sarepta Says Deaths of Two Elevidys Patients Posted on FDA Database Unrelated to Treatment
Sarepta Therapeutics (NASDAQ: SRPT) said Friday that the deaths of two patients taking its marketed gene therapy Elevidys®…